Insider Transactions in Q1 2020 at Eli Lilly & CO (LLY)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
38,962
-0.03%
|
$5,454,680
$140.07 P/Share
|
|
Mar 30
2020
|
Stephen F Fry SVP, HR & Diversity |
SELL
Open market or private sale
|
Direct |
14,657
-3.08%
|
$1,978,695
$135.67 P/Share
|
|
Mar 30
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.04%
|
$29,190,000
$139.94 P/Share
|
|
Mar 16
2020
|
Johna Norton EVP, Global Quality |
SELL
Open market or private sale
|
Direct |
4,727
-21.1%
|
$619,237
$131.0 P/Share
|
|
Mar 16
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$1,935
$129.38 P/Share
|
|
Mar 04
2020
|
Myles O'Neill SVP & Pres., Mfg. Operations |
SELL
Open market or private sale
|
Indirect |
25,000
-74.7%
|
$3,500,000
$140.15 P/Share
|
|
Mar 02
2020
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
3,700
-43.84%
|
$473,600
$128.0 P/Share
|
|
Feb 18
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.02%
|
$1,974
$141.01 P/Share
|
|
Feb 16
2020
|
Johna Norton EVP, Global Quality |
SELL
Payment of exercise price or tax liability
|
Indirect |
34
-20.99%
|
$4,794
$141.12 P/Share
|
|
Feb 16
2020
|
Johna Norton EVP, Global Quality |
BUY
Exercise of conversion of derivative security
|
Indirect |
97
+37.45%
|
-
|
|
Feb 11
2020
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
BUY
Grant, award, or other acquisition
|
Direct |
5,588
+16.35%
|
$804,672
$144.25 P/Share
|
|
Feb 11
2020
|
Stephen F Fry SVP, HR & Diversity |
BUY
Grant, award, or other acquisition
|
Direct |
14,657
+10.72%
|
$2,110,608
$144.25 P/Share
|
|
Feb 11
2020
|
Patrik Jonsson EVP&Pres, LLY Dia&Obe, LLY USA |
BUY
Grant, award, or other acquisition
|
Direct |
5,702
+18.52%
|
$821,088
$144.25 P/Share
|
|
Feb 11
2020
|
Michael B Mason EVP & Pres., Lilly Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
5,785
+27.79%
|
$833,040
$144.25 P/Share
|
|
Feb 11
2020
|
Johna Norton EVP, Global Quality |
BUY
Grant, award, or other acquisition
|
Direct |
1,778
+7.35%
|
$256,032
$144.25 P/Share
|
|
Feb 11
2020
|
Myles O'Neill SVP & Pres., Mfg. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,349
+8.85%
|
$626,256
$144.25 P/Share
|
|
Feb 11
2020
|
David A Ricks President, Chair, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
77,586
+22.43%
|
$11,172,384
$144.25 P/Share
|
|
Feb 11
2020
|
Aarti S. Shah SVP & CIDO |
BUY
Grant, award, or other acquisition
|
Direct |
3,767
+15.16%
|
$542,448
$144.25 P/Share
|
|
Feb 11
2020
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Grant, award, or other acquisition
|
Direct |
21,341
+18.01%
|
$3,073,104
$144.25 P/Share
|
|
Feb 11
2020
|
Joshua L Smiley |
BUY
Grant, award, or other acquisition
|
Direct |
5,447
+12.84%
|
$784,368
$144.25 P/Share
|
|
Feb 11
2020
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
7,079
+19.55%
|
$1,019,376
$144.25 P/Share
|
|
Feb 11
2020
|
Donald A Zakrowski SVP, Finance, & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,845
+31.3%
|
$553,680
$144.25 P/Share
|
|
Feb 11
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
18,322
+24.44%
|
-
|
|
Feb 05
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
200,000
-0.09%
|
$29,200,000
$146.73 P/Share
|
|
Feb 01
2020
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Payment of exercise price or tax liability
|
Direct |
2,174
-8.64%
|
$302,186
$139.64 P/Share
|
|
Feb 01
2020
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
BUY
Exercise of conversion of derivative security
|
Direct |
4,896
+16.29%
|
-
|
|
Feb 01
2020
|
Stephen F Fry SVP, HR & Diversity |
SELL
Payment of exercise price or tax liability
|
Direct |
5,851
-5.17%
|
$813,289
$139.64 P/Share
|
|
Feb 01
2020
|
Stephen F Fry SVP, HR & Diversity |
BUY
Exercise of conversion of derivative security
|
Direct |
13,055
+10.33%
|
-
|
|
Feb 01
2020
|
David A Ricks President, Chair, and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,089
-13.71%
|
$4,321,371
$139.64 P/Share
|
|
Feb 01
2020
|
David A Ricks President, Chair, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
69,350
+23.42%
|
-
|
|
Feb 01
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
7,299
-16.0%
|
$1,014,561
$139.64 P/Share
|
|
Feb 01
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
BUY
Exercise of conversion of derivative security
|
Direct |
16,317
+26.34%
|
-
|
|
Jan 31
2020
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
5,000
-2.56%
|
-
|
|
Jan 21
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.02%
|
$1,960
$140.91 P/Share
|
|
Jan 13
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.09%
|
$28,495,000
$139.23 P/Share
|
|
Jan 10
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.18%
|
$28,980,000
$138.0 P/Share
|
|
Jan 09
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.1%
|
$29,920,000
$136.06 P/Share
|
|
Jan 08
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
172,650
-0.08%
|
$22,962,450
$133.6 P/Share
|
|
Jan 07
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
32,645
-0.03%
|
$4,309,140
$132.9 P/Share
|